Dln Drugs Private Limited

Dln Drugs Private Limited - pharma in Puri, Orissa, India. FY 2026 financials and compliance.
CIN U51909OR2022PTC040047 Incorporated 21 June 2022 ROC Cuttack HQ Puri, Orissa, India
Active Private Limited Company pharma
Data last updated
Revenue · FY 2024
₹20.2 Cr
▲ 278.00% YoY
EBITDA · FY 2024
Locked
In full report
Net profit · FY 2024
Locked
In full report
Authorised capital
₹1.5 Cr
Registered with MCA
Paid-up capital
₹1.5 Cr
Issued & subscribed
Open charges
₹3.25 Cr
Secured borrowings
Company age
4 yrs
Est. 2022
Last financials
Mar 2024
Balance sheet date

About Dln Drugs Private Limited

Data last updated: 06 February 2026

Dln Drugs Private Limited is a private limited company based in Puri, Orissa, India. It specialises in pharmaceutical retail and distribution, a part of the broader pharmaceuticals sector. Incorporated on 21 June 2022.

Registered with ROC Cuttack under CIN U51909OR2022PTC040047.

Capital: an authorised share capital of ₹1.5 Cr and a paid-up capital of ₹1.5 Cr. It is led by directors Pradeep Kumar Pani and Kumudini Pani.

Last AGM: 30 September 2025. Financial statements filed for year ended 31 March 2024. Office: Plot No – 560/2637 1St Floor White Rose Pubasasan Kausalyaganga, Puri, Orissa, India – 751002.

As per the financials filed for FY 2024, the company reported a revenue of ₹20.2 Cr, reflecting significant growth compared to the previous year.

As per MCA filings, the company has open charges of ₹3.25 Cr on record.

Company Details of Dln Drugs Private Limited
CIN U51909OR2022PTC040047
Registration Number 040047
Incorporation Date 21 June 2022
ROC Cuttack
Listing Status Unlisted
Company Status Active
Date of Last AGM 30 September 2025
Date of Balance Sheet 31 March 2024
Contact Details
  • Email
    Locked
  • Telephone
    Locked
  • Website
    Locked
  • Social Media
    Locked
  • Registered Address
    Plot No – 560/2637 1St Floor White Rose Pubasasan Kausalyaganga, Puri, Orissa, India – 751002
  • Industry
    Pharma, Pharmaceutical Retailers & Distributors
Company report
Dln Drugs Private Limited - full intelligence report
  • Historical Financials and ratios
  • Shareholding pattern and group structure
  • Charges with holder and property details
  • Litigation, compliance and MCA filings
  • PDF report delivered after checkout
₹799 ₹999 20% off
Secure checkout · GST invoice included

Unlock the full Dln Drugs Private Limited report

Financials, compliance, directors, charges, ownership and filings for Dln Drugs Private Limited in one report.

10-year financials Directors & ownership Charges & compliance

Business Activity of Dln Drugs Private Limited

Dln Drugs Private Limited is engaged in the principal business activity of wholesale and retail trade; repair of motor vehicles and motorcycles, with detailed activities including wholesale trade, except of motor vehicles and motorcycles.

Main Activity Group Code Description of Main Activity Business Activity Code Description of Business Activity Turnover Percentage
G Wholesale and retail trade; repair of motor vehicles and motorcycles 46 Wholesale trade, except of motor vehicles and motorcycles Locked
Premium access

Business activity turnover details for Dln Drugs Private Limited

Turnover contribution percentages and historical activity changes require an active report plan.

  • Turnover contribution
  • Historical classifications
  • Filing-level activity changes

Verified entity values are shown only after access is granted.

Auditor Details of Dln Drugs Private Limited

Dln Drugs Private Limited is audited by PBSD & ASSOCIATES for the financial year 2023. The auditor plays a crucial role in ensuring financial transparency and compliance with accounting standards.

Name Status Appointment Date Cessation Date
PBSD & ASSOCIATES Locked Locked Locked
Premium access

Complete auditor history for Dln Drugs Private Limited

Appointment status, appointment dates, cessation dates, and historical auditor changes require an active report plan.

  • Appointment status
  • Appointment dates
  • Cessation dates
  • Auditor changes

Verified entity values are shown only after access is granted.

Board of Directors of Dln Drugs Private Limited

Dln Drugs Private Limited is currently managed by 2 directors, with 4 former directors having served the organization. The current Directors play a crucial role in shaping the company's strategic direction and governance.

Current Directors
Name Designation Appointment Date Tenure Status
Pradeep Kumar Pani Director 21 Jun 2022 4 Years 2 Months Current
Kumudini Pani Director 20 Feb 2025 1 Years 6 Months Current

Financials of Dln Drugs Private Limited FY 2024 filings available

Dln Drugs Private Limited reported revenue of ₹20.2 Cr (up 278.00% YoY) for FY 2024.

Revenue · FY 2024
₹20.2 Cr ▲ 278.00%
Premium access

Ten-year financial statements for Dln Drugs Private Limited

Historical statement values and trend charts require an active report plan.

  • Income statements
  • Balance sheets
  • Cash-flow statements
  • Ratios and benchmarks

Verified entity values are shown only after access is granted.

Ownership and Shareholding of Dln Drugs Private Limited

Premium access

Shareholding and ownership data for Dln Drugs Private Limited

Promoter, institutional, public, and beneficial ownership values require an active report plan.

  • Ownership categories
  • Historical changes
  • Group structure
  • FII and DII holdings

Verified entity values are shown only after access is granted.

Charges & Borrowings of Dln Drugs Private Limited

Open charges
₹3.25 Cr
Satisfied charges
₹0
Breakdown by lending institutions
State Bank of India₹3.25 Cr
Latest charge details
DateLenderAmountStatus
23 Nov 2022 State Bank of India ₹3.25 Cr Open

Total charge records: 1 View all charges

Employees and EPFO Compliance at Dln Drugs Private Limited

Dln Drugs Private Limited has a workforce of 0 employees as of Apr 07, 2024.

Active EPFO establishments
1
Premium access

Employee and EPFO history for Dln Drugs Private Limited

Monthly headcount, contribution history, establishment records, and filing compliance require an active report plan.

  • Monthly headcount
  • PF contributions
  • ECR filing status
  • Establishment history

Verified entity values are shown only after access is granted.

GST Compliance of Dln Drugs Private Limited

Premium access

GST registrations and filing compliance for Dln Drugs Private Limited

State-wise registrations, return filing status, HSN and SAC details, and jurisdiction records require an active report plan.

  • GSTIN registrations
  • State-wise filing status
  • HSN and SAC details
  • Tax jurisdiction records

Verified entity values are shown only after access is granted.

Credit Ratings, Litigation & Regulatory Alerts for Dln Drugs Private Limited

Premium access

Credit ratings, litigation, and regulatory alerts for Dln Drugs Private Limited

Agency ratings, court records, regulatory events, and entity-specific compliance alerts require an active report plan.

  • Rating history
  • Court and tribunal cases
  • Regulatory alerts
  • Director-linked violations

Verified entity values are shown only after access is granted.

MSME Payment Delays by Dln Drugs Private Limited

Premium access

MSME payment history for Dln Drugs Private Limited

Amounts outstanding to micro and small suppliers, delay reasons, and MSME-1 filing history require an active report plan.

  • Outstanding amounts
  • Delay periods and reasons
  • MSME-1 filing history
  • Vendor payment signals

Verified entity values are shown only after access is granted.

Subsidiaries & Group Companies of Dln Drugs Private Limited

Premium access

Corporate group structure for Dln Drugs Private Limited

Parent, subsidiary, associate, joint venture, and ownership records require an active report plan.

  • Parent company
  • Subsidiaries and ownership
  • Associates and joint ventures
  • Entity investments

Verified entity values are shown only after access is granted.

MCA Filings & Documents of Dln Drugs Private Limited

Premium access

MCA filings and documents for Dln Drugs Private Limited

Official forms, annual returns, financial statements, charge filings, and document dates require an active report plan.

  • Incorporation documents
  • Annual returns and statements
  • Charge filings
  • Complete filing index

Verified entity values are shown only after access is granted.

Recent Activity on Dln Drugs Private Limited

Activity
30 Sep 2025
Dln Drugs Private Limited last Annual general meeting of members was held on 30 Sep 2025 as per latest MCA records.
Charges
19 Sep 2025
A charge with State Bank Of India of Rs. 3.25 Cr registered on 23 Nov 2022 with Charge ID 100653985 was modified on 19 Sep 2025.
Directors
20 Feb 2025
Kumudini Pani was appointed as a Director on 20 Feb 2025 & has been associated with this company since 1 year 6 months.
Activity
31 Mar 2024
Dln Drugs Private Limited has filed its annual Financial statements for the year ended 31 Mar 2024 with Roc Cuttack.
Charges
23 Nov 2022
A charge with State Bank Of India amounted to Rs. 3.25 Cr with Charge ID 100653985 was registered on 23 Nov 2022.
Directors
21 Jun 2022
Pradeep Kumar Pani was appointed as a Director on 21 Jun 2022 & has been associated with this company since 4 years 2 months.

Frequently Asked Questions about Dln Drugs Private Limited

Dln Drugs Private Limited is an active private limited company in the pharma sector based in Puri, Orissa, India. It was incorporated on 21 June 2022 (4+ years old) and is registered under CIN U51909OR2022PTC040047.

Dln Drugs Private Limited reported revenue of ₹20.2 Cr for FY 2024 (up 278.00% YoY).

The current directors of Dln Drugs Private Limited are:

The primary industry of Dln Drugs Private Limited is pharma. The company specifically operates in pharmaceutical retailers and distributors. The company is currently active in this sector.

Dln Drugs Private Limited can be reached at the registered office: Plot No – 5602637 1St Floor White Rose Pubasasan Kausalyaganga, Puri, Orissa, India – 751002.

The authorised capital is ₹1.5 Cr, and the paid-up capital is ₹1.5 Cr.

7M+ Indian companies. One platform.

Financials, directors, compliance, charges and shareholding - sourced from MCA, SEBI and RBI filings.

Subscription plans available